Variants within ATP8B2, a plasmalogen transporter, are associated with motor deficit progression of PD-afflicted patients [209], and reduced levels of plasmalogens cause a human genetic disorder, rhizomelic chondrodysplasia punctata (RCDP), characterized by severe neurological symptoms [210]. Here, ATP8B2 is linked to rhizomelic chondrodysplasia punctata.